1. Home
  2. GKOS vs ROAD Comparison

GKOS vs ROAD Comparison

Compare GKOS & ROAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ROAD
  • Stock Information
  • Founded
  • GKOS 1998
  • ROAD 2001
  • Country
  • GKOS United States
  • ROAD United States
  • Employees
  • GKOS N/A
  • ROAD N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ROAD Engineering & Construction
  • Sector
  • GKOS Health Care
  • ROAD Industrials
  • Exchange
  • GKOS Nasdaq
  • ROAD Nasdaq
  • Market Cap
  • GKOS 5.8B
  • ROAD 5.9B
  • IPO Year
  • GKOS 2015
  • ROAD 2018
  • Fundamental
  • Price
  • GKOS $94.00
  • ROAD $121.37
  • Analyst Decision
  • GKOS Strong Buy
  • ROAD Buy
  • Analyst Count
  • GKOS 12
  • ROAD 3
  • Target Price
  • GKOS $131.17
  • ROAD $112.33
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • ROAD 608.8K
  • Earning Date
  • GKOS 11-03-2025
  • ROAD 08-07-2025
  • Dividend Yield
  • GKOS N/A
  • ROAD N/A
  • EPS Growth
  • GKOS N/A
  • ROAD 2.44
  • EPS
  • GKOS N/A
  • ROAD 1.37
  • Revenue
  • GKOS $432,953,000.00
  • ROAD $2,450,670,000.00
  • Revenue This Year
  • GKOS $28.79
  • ROAD $55.82
  • Revenue Next Year
  • GKOS $25.65
  • ROAD $17.07
  • P/E Ratio
  • GKOS N/A
  • ROAD $88.44
  • Revenue Growth
  • GKOS 26.70
  • ROAD 39.18
  • 52 Week Low
  • GKOS $77.10
  • ROAD $56.52
  • 52 Week High
  • GKOS $163.71
  • ROAD $124.12
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • ROAD 61.53
  • Support Level
  • GKOS $89.83
  • ROAD $115.00
  • Resistance Level
  • GKOS $97.00
  • ROAD $124.12
  • Average True Range (ATR)
  • GKOS 2.65
  • ROAD 4.18
  • MACD
  • GKOS 0.39
  • ROAD 0.09
  • Stochastic Oscillator
  • GKOS 71.27
  • ROAD 85.73

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

Share on Social Networks: